Skip to content

Further Study on Effect of Shigru-Haridradi Eye Drop and Rasayana yoga in the management of Vataja Abhishyanda(Simple Allergic Conjunctivitis)

Further Study On Efficacy Of Shigru-Haridradi Eye Drop And Rasayana Yoga In The Management Of Vataja Abhishyanda (Simple Allergic Conjunctivitis)- An Open Labelled Randomized Comparative Clinical Trial.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029914
Enrollment
30
Registered
2020-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

Intervention1: Shigru-Haridradi Eye Drop : In Group A Shigru-Haridradi Eye Drop(Anubhuta) Route of administration: Local Dose: 1 drop 4 times per day Duration:1month Minimum Patients: 15 Control In

Sponsors

Institute for Post graduate teaching and Research in Ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with typical signs and symptoms of Vataja Abhishyanda (Simple Allergic Conjunctivitis) are Nistoda (Pricking Pain), Sangharsh (Foreign body sensation), Ragata (Redness), Vishushka Bhava (Dryness feeling), Achchasruta (Clean/ Watery discharge), Alpa Shopha (Mild Chemosis), Chala Ruja (Reffered Pain), Kandu (Itching) Daha(burning sensation) 2.Patients between 16 to 40 years of age.

Exclusion criteria

Exclusion criteria: 1.Patients having complications like corneal involvement like Marginal Corneal Ulcer, Dacryocystitis, Trachoma, Keratoconjunctivitis sicca, Vernal keratoconjunctivitis, Giant papillary conjunctivitis, Atopic keratoconjunctivitis. 2.Patients below 16 years and above 40 years of age. 3.All types of Conjunctivitis (Acute and Chronic) which are non-allergic in nature are excluded from the Study.

Design outcomes

Primary

MeasureTime frame
Changes in signs and symptoms of Vataja AbhishyandaTimepoint: At the end of followup period of one month

Secondary

MeasureTime frame
Improvement in Quality of life and social well being of patientTimepoint: At the end of followup period

Countries

India

Contacts

Public ContactDr Deepak Pawar

Institute for Post graduate teaching and Research in Ayurved

drdeep29@gmail.com7737379173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026